Pfizer Limited

Ramsgate Road, Sandwich, Kent, CT13 9NJ
Telephone: +44 (0)1304 616 161
Fax: +44 (0)1304 656 221
Patient Information Leaflet last updated on the eMC: 03/11/2009
PIL Lustral

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 03/11/2009 and displayed until Current
Reasons for adding or updating:
  • Change due to harmonisation of PIL.
Updated on 23/04/2008 and displayed until 03/11/2009
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 05/03/2008 and displayed until 23/04/2008
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 30/10/2007 and displayed until 05/03/2008
Reasons for adding or updating:
  • Change to, or new, use for medicine
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to date of revision
Updated on 15/03/2006 and displayed until 30/10/2007
Reasons for adding or updating:
  • Change of manufacturer
  • Change of licence holder
  • Change to date of revision
Updated on 10/02/2004 and displayed until 15/03/2006
Reasons for adding or updating:
  • Update to PIL
Updated on 24/06/2003 and displayed until 10/02/2004
Reasons for adding or updating:
  • Update to PIL
Updated on 17/05/2002 and displayed until 24/06/2003
Reasons for adding or updating:
  • Update to PIL
Updated on 20/02/2001 and displayed until 17/05/2002
Reasons for adding or updating:
  • No reasons supplied
Updated on 26/01/2000 and displayed until 20/02/2001
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
   sertraline hydrochloride


© 2009 Datapharm Communications Ltd

Go to www.medicines.org.uk